Rice’s Ken Kennedy Institute is hosting the third annual AI in Health Conference Sept. 9-12 with themes this year including foundation models in medicine, LLM applications, AI in neuroscience and neurotechnology, digital twins in health care and patient engagement and equity in health AI.
Rice and the University of Texas MD Anderson Cancer Center today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.
Rice University’s Synthesis X Center (SynthX) and Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center have jointly awarded their first innovation seed grants to three teams of research collaborators from Rice and Baylor.
Rice has created the new Synthesis X Center to bring together clinicians treating cancer and researchers looking for cures to help spur drug discovery make precision adjustments to drug properties and translate fundamental research discoveries into clinical applications.
Rice engineer Jacob Robinson participated in the first “Houston Day: Beyond the Bayou” program organized by the Greater Houston Partnership, which brought together state legislators from across Texas for a two-day legislative advocacy event in Houston earlier this month.
Rice University researchers in the lab of chemist Han Xiao have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients.
Rice University has launched its Medical Humanities Research Institute, the only institute in the United States and one of few in the world solely dedicated to advancing translational research on human experiences of health and illness.
The Advanced Research Projects Agency for Health has awarded a Rice-led team $45 million to rapidly develop an implant with sense-and-respond technology that could slash U.S. cancer-related deaths by more than 50%.
Rice University today introduced the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
Rice bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where the disease kills more than 300,000 women each year.
More than 160 leaders in neurotechnology, neuroscience, neuroengineering and neurosurgery attended InterfaceRice 2023, the inaugural conference of the Rice Neuroengineering Initiative, May 18-19.
Researchers from Rice and Baylor College of Medicine are developing a first-of-its-kind “glyco-immune” checkpoint inhibitor for breast cancer survivors who develop metastatic bone cancer.
The Rice360 Institute for Global Health Technologies presented its 2023 Global Champion Award to philanthropist Jan Duncan and its 2023 Alumni Leadership Award to physician Elizabeth Spiegel ’11 at its graduate recognition and awards breakfast May 5.